• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Cell Cycle
You are here: Product Lines > Cell Cycle
Toolbar - View Selection
 
 Items 20-40 of 185 Page 2 of 10 Select Page: << 1 2 3 4 5 6 7 8 9 10  >>  
ALX-270-393 Revised 17-Jul-07
CVT-313
Add to Clipboard
SYNONYMS 6-(4-Methoxybenzylamino)-2-[bis(2-hydroxyethylamino)]-9-isopropylpurine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-393-M001   1 mg 60.00 USD Add To Cart
ALX-270-393-M005   5 mg 240.00 USD Add To Cart
Product Specification
FORMULA: C20H28N6O3
MW: 400.5
PURITY: ≥98% (HPLC)
APPEARANCE: White crystalline solid.
SOLUBILITY: Soluble in DMSO, dimethyl formamide or 100% ethanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from moisture.

Product Description
Specific inhibitor of CDK2/cyclin A (IC50=500nM) and CDK2/cyclin  E  (IC50=500nM). Also inhibits CDK1/cyclin B (IC50=4.2µM) and CDK4/cyclin D1 (IC50=215µM).
Product Specific Literature References
CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation: E.E. Brooks, et al.; J. Biol. Chem. 272, 29207 (1997) Abstract; Full Text
Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling: R.N. Bhattacharjee, et al.; Mol. Cell. Biol. 21, 5417 (2001) Abstract; Full Text
 
 
ALX-270-394 Revised 21-Sep-05
NU2058
Add to Clipboard
SYNONYMS O6-Cyclohexylmethylguanine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-394-M005   5 mg 80.00 USD Add To Cart
ALX-270-394-M025   25 mg 290.00 USD Add To Cart
Product Specification
FORMULA: C12H17N5O
MW: 247.3
CAS NUMBER: 161058-83-9
SOLUBILITY: Soluble in water or DMSO.
SHIPPING: AMBIENT
LONG TERM STORAGE: +4°C
HAZARD: IRRITANT.

Product Description
Competitive inhibitor of CDK1/cyclin B (IC50=5µM) and CDK2/cyclin A (IC50=12µM). Pharmacologically distinct from the relative specific inhibitor of CDK1/2 roscovitine (Prod. No. ALX-350-251).
Product Specific Literature References
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles: C.E. Arris, et al.; J. Med. Chem. 43, 2797 (2000) Abstract
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death: M. Ferguson, et al.; Cell Cycle 3, 80 (2004) Abstract
 
 
ALX-270-395 Revised 08-Dec-04
2-Hydroxybohemine
Add to Clipboard
SYNONYMS 6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-395-M001   1 mg 60.00 USD Add To Cart
ALX-270-395-M005   5 mg 240.00 USD Add To Cart
Product Specification
FORMULA: C18H24N6O2
MW: 356.4
PURITY: ≥95%
FORMULATION: Off-white solid.
SOLUBILITY: 100µM soluble in DMSO, dimethyl formamide or 100% ethanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from light.

Product Description
Inhibitor of CDK1 (IC50=100nM) and CDK2 (IC50=80nM).
Product Specific Literature References
Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases: K. Vermeulen, et al.; Leukemia 16, 299 (2002) Abstract
 
 
ALX-270-396 Revised 07-Mar-08
Olomoucine II
Add to Clipboard
SYNONYMS 6-(2-Hydroxybenzylamino)-2(R)-[[1-hydroxymethyl)propyl]amino]-9-isopropylpurine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-396-M001   1 mg 42.00 USD Add To Cart
ALX-270-396-M005   5 mg 145.00 USD Add To Cart
Product Specification
FORMULA: C19H26N6O2
MW: 370.5
CAS NUMBER: 500735-47-7
PURITY: ≥98%
APPEARANCE: White to off-white crystalline solid.
SOLUBILITY: Soluble in DMSO, dimethyl formamide or 100% ethanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C

Product Description
Selective inhibitor of CDK1/cyclin B (IC50=20nM). Potent cytotoxin in tumor cells: IC50=5.3µM against MCF7 cells, IC50=11.1µM against K562 cells, IC50=3.0µM against CEM cells, IC50=6.3µM against HOS cells, and IC50=6.3µM against G361 cells.
Product Specific Literature References
Synthesis and biological activity of olomoucine II: V. Krystof, et al.; Bioorg. Med. Chem. Lett. 12, 3283 (2002) Abstract
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor: V. Krystof, et al.; Cell Mol. Life Sci. 62, 1763 (2005) Abstract
Further Categories Containing This Product:
Antitumor Agents (Enzyme Inhibitors)Antitumor Agents (Apoptosis Inducers)
 
 
ALX-270-397 Revised 09-Jan-08
Olomoucine, N9-Isopropyl-
Add to Clipboard
SYNONYMS 6-Benzylamino-2-(2-hydroxyethylamino)-9-Isopropylpurine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-397-M001   1 mg 40.00 USD Add To Cart
ALX-270-397-M005   5 mg 120.00 USD Add To Cart
Product Specification
FORMULA: C17H22N6O
MW: 326.4
CAS NUMBER: 158982-15-1
PURITY: ≥98% (HPLC)
APPEARANCE: White to off-white crystalline solid.
SOLUBILITY: Soluble in DMSO or dimethyl formamide; sparingly soluble in methanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
USE/STABILITY: Stock solutions are stable for 3 months when stored at -20°C.

Product Description
Inhibitor of CDK1/cyclin B (IC50=2µM) and CDK5/p35 (IC50=3µM).
Product Specific Literature References
Inhibition of cyclin-dependent kinases by purine analogues: J. Vesely, et al.; Eur. J. Biochem. 224, 771 (1994) Abstract
Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis: F.I. Raynaud, et al.; Mol. Cancer Ther. 3, 353 (2004) Abstract
 
 
ALX-270-398 Revised 06-Feb-05
PNU 112455A . hydrochloride
Add to Clipboard
SYNONYMS N4-(6-Aminopyrimidin-4-yl)-sulfanilamide . HCl
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-398-M001   1 mg 34.00 USD Add To Cart
ALX-270-398-M005   5 mg 135.00 USD Add To Cart
Product Specification
FORMULA: C10H11N5O2S . HCl
MW: 265.3 . 36.5
PURITY: ≥95%
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in DMSO or water.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
HANDLING: Protect from light and moisture. Packaged under inert gas. Hygroscopic.

Product Description
Selective and ATP-competitive inhibitor of CDK2/cyclin E  (Ki=2µM) and CDK5/p25 (Ki=2µM). Binds to the ATP-binding pocket of CDK2. Does not affect the activities of c-met, IGF-1 receptor tyrosine kinase, cAMP-dependent kinase and ERK2 at concentrations as high as 100µM.
Product Specific Literature References
The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism: P.M. Clare, et al.; J. Biol. Chem. 276, 48292 (2001) Abstract; Full Text
 
 
ALX-270-400 Revised 31-Mar-05
SU 9516
Add to Clipboard
SYNONYMS 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-400-M005   5 mg 80.00 USD Add To Cart
ALX-270-400-M025   25 mg 320.00 USD Add To Cart
Inquire
Product Specification
FORMULA: C13H11N3O2
MW: 241.3
PURITY: ≥95%
APPEARANCE: Yellow to orange solid.
SOLUBILITY: Soluble in DMSO (10mg/ml).
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
HANDLING: Protect from light. Packaged under inert gas.

Product Description
Cell permeable, potent, selective and ATP-competitive inhibitor of CDK2/cyclin A (IC50=22nM), CDK1/cyclin B (IC50=40nM) and CDK4/cyclin D1 (IC50=200nM). Has no effect on the activity of PKC, p38, PDGFRβ and EGFR (IC50>10µM). Displays anti-proliferative and pro-apoptotic properties in tumor cells. Inhibits proliferation of growth factor-stimulated colon carcinoma cells by binding to CDK2 and thus preventing the phosphorylation of pRb and its dissociation from E2F.
Product Specific Literature References
A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells: M.E. Lane, et al.; Cancer Res. 61, 6170 (2001) Abstract
SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells: B. Yu, et al.; Biochem Pharmacol. 64, 1091 (2002) Abstract
SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2: D.J. Moshinsky, et al.; BBRC 310, 1026 (2003) Abstract
Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-dependent kinase 2 inhibitors: X. Li, et al.; Bioorg. Med. Chem. Lett. 13, 1939 (2003) Abstract
 
 
ALX-270-403 Revised 12-Jun-08
2-Bromo-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
Add to Clipboard
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-403-M001   1 mg 115.00 USD Add To Cart
Product Specification
FORMULA: C20H10BrN3O2
MW: 404.2
PURITY: ≥95% (HPLC)
APPEARANCE: Yellow solid.
SOLUBILITY: Soluble in DMSO.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
USE/STABILITY: Stock solutions are stable for up to 2 months if stored at -20°C.
HANDLING: Packaged under inert gas. Protect from light. After reconstitution, prepare aliquots and store at -20°C.
HAZARD: TOXIC.
IDENTITY: Identity determined by NMR.

Product Description
Cell permeable, unsymmetrical compound that displays antiproliferative properties. Potent, selective and ATP-competitive inhibitor of CDK4/cyclin D1 (IC50=76nM), CDK2/cyclin E (IC50=520nM) and CDK1/cyclin B (IC50=2.1µM). Shows little activity towards CaMKII, PKA and GSK-3β (IC50>20µM).
Product Specific Literature References
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors: G. Zhu, et al.; J. Med. Chem. 46, 2027 (2003) Abstract
 
 
ALX-270-419 Revised 08-Oct-08
NU6102
Add to Clipboard
SYNONYMS O6-Cyclohexylmethyl-2-(4’-sulfamoylanilino)purine
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-419-M001   1 mg 50.00 USD Add To Cart
ALX-270-419-M005   5 mg 145.00 USD Add To Cart
Product Specification
FORMULA: C18H22N6O3S
MW: 402.5
PURITY: ≥95%
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in DMSO.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from light. Packaged under inert gas.
HAZARD: MAY BE CARCINOGENIC. HARMFUL.

Product Description
1,000-fold more potent inhibitor of CDK1/cyclin B (IC50=9.5nM) and CDK2/cyclin A3 (IC50=5.4nM) than NU2058 (Prod. No. ALX-270-394). Selective for CDK1 and CDK2 compared to CDK4/D1 (IC50=1.6µM), DYRK1A (IC50=0.9µM), PDK1 (IC50=0.8µM) and ROCKII (IC50=0.6µM).

Product Specific Literature References
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor: T.G. Davies, et al.; Nat. Struct. Biol. 9, 745 (2002) Abstract
Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2: K.L. Sayle, et al.; Bioorg. Med. Chem. Lett. 13, 3079 (2003) Abstract
N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2: I.R. Hardcastle, et al.; J. Med. Chem. 47, 3710 (2004) Abstract
Further Categories Containing This Product:
Carcinogens & Tumor Promoters Other Products
 
 
ALX-270-424 Revised 13-Feb-07
5-Iodo-indirubin-3'-monoxime
Add to Clipboard
PRODUCT LINE Cell Cycle
PRODUCT CATEGORY CDK & Cyclin Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-270-424-M001   1 mg 90.00 USD Add To Cart
Product Specification
FORMULA: C16H10IN3O2
MW: 403.2
PURITY: ≥98% (1H-NMR)
APPEARANCE: Dark red solid.
SOLUBILITY: Soluble in DMSO (1M).
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Protect from light.

Product Description
Potent inhibitor of GSK-3β (IC50=9nM). Also inhibits CDK1/cyclin B (IC50=25nM) and CDK5/p25 (IC50=20nM) by binding to the ATP-binding pocket.
Product Specific Literature References
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer’s disease. A property common to most cyclin-dependent kinase inhibitors?: S. Leclerc, et al.; J. Biol. Chem. 276, 251 (2001) Abstract; Full Text
Further Categories Containing This Product:
GSK-3 Inhibitors
 
 
ALX-270-441 Revised 18-Aug-08
NU6140